What are the recommendations for using the Twiist AID (Automated Insulin Delivery) system with a tube for continuous insulin infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Twiist AID System with Tubed Infusion Set: Key Recommendations

The Twiist AID system with tubed infusion sets requires the same critical attention to infusion site management as all tubed pump systems, with infusion set changes every 48-72 hours being essential to prevent the "Achilles heel" of insulin delivery interruption that can compromise automated insulin delivery performance. 1

Critical Infusion Set Management

Change Frequency

  • Change infusion sets every 48-72 hours to minimize infusion site adverse events and prevent metabolic deterioration 1, 2
  • This timeframe is patient-dependent and should be adjusted based on individual response, but extending beyond 72 hours significantly increases complication risk 2
  • The tubed infusion set remains the most vulnerable component of any AID system, capable of silent occlusion or complete blockage without warning 1

Site Rotation Protocol

  • Rotate infusion sites at least 1 cm (half an inch) away from the previous insertion point 1
  • Preferred anatomical sites include: abdomen, upper third anterior lateral thighs, posterior lateral upper buttocks and flanks, and middle third posterior upper arm 2
  • Check infusion sites at least annually by a healthcare provider for lipohypertrophy, nodules, scarring, or inflammation 1, 2

Troubleshooting Unexplained Hyperglycemia

Infusion Set Failure Detection

  • Always suspect infusion set occlusion or failure when experiencing unexplained hyperglycemia or glucose variability 1
  • Without automated algorithms for site failure detection, manual problem-solving is essential—assume insulin flow interruption until proven otherwise 1
  • If lipohypertrophy is detected, immediately stop infusing into affected areas and insert the catheter into healthy tissue 1, 2

System Reversion Awareness

  • Understand when your Twiist system automatically reverts to manual mode (preprogrammed basal rates) 1
  • Missing CGM data or loss of connectivity triggers reversion to manual settings, which may not reflect current insulin requirements 1
  • Update manual mode settings (basal rates, correction factors) periodically even while using AID, as overall insulin needs change over time 1

Essential User Competencies

Technical Requirements

  • You must be capable of troubleshooting infusion set issues, recognizing when to revert to manual insulin delivery, and understanding all system limitations 1
  • Maintain backup supplies including extra infusion sets, insulin, and alternative insulin delivery methods (pens or syringes) 1
  • Ensure ability to independently problem-solve hyperglycemia by checking for failed infusion sets or broken system components 1

Behavioral Expectations

  • Continue manual bolusing for meals—current AID systems are hybrid systems requiring user input for prandial insulin 1
  • Avoid "stacking" correction boluses; the system should account for insulin-on-board automatically 3
  • Do not add "fake carbs" to manipulate the system or overcorrect hyperglycemia 1

Settings Optimization

When to Adjust Parameters

  • Recalculate correction factor using 1500/TDD or 1700/TDD formula every 3-6 months or when significant changes in weight, activity, or insulin requirements occur 3
  • If correction doses consistently fail to bring glucose into target range, adjust the correction factor rather than basal insulin 3
  • Monitor whether automated corrections are bringing glucose to target 2-4 hours post-correction 3

Basal Rate Adjustments

  • Approximately 40-60% of total daily dose should be basal delivery, with remainder as mealtime and correction boluses 3
  • Titrate basal insulin to achieve acceptable fasting glucose before adjusting other parameters 4
  • Make only one setting change at a time to determine effectiveness 4

Special Situations Requiring Manual Mode

When to Disable AID

  • During acute illness with ketosis (even without elevated glucose), as resolution requires increased insulin delivery that AID may not provide rapidly enough 1
  • When starting systemic steroids, as AID systems may not respond quickly enough to dramatically increased insulin requirements 1
  • During pregnancy, as lower glycemic targets may not be achievable with standard AID settings 1

Environmental Considerations

  • Be aware that exposure to high or low temperatures, magnetic fields, or water can impact system function 1
  • Understand how physical activity affects insulin requirements, as current AID systems may not optimally handle exercise-related needs 1

Data Management and Support

Healthcare Provider Access

  • Ensure your healthcare provider has easy remote access to your AID system data 1
  • Understand whether you need to manually upload data or if it transmits automatically 1
  • Establish clear follow-up protocols for dose optimization, particularly during early use 1

Common Pitfalls to Avoid

  • Never share insulin cartridges or pens between patients due to blood-borne disease transmission risk 1
  • Do not ignore unexplained glucose variability—always investigate for infusion site issues 1, 2
  • Avoid making multiple setting changes simultaneously, as this prevents identifying which change was effective 4
  • Do not rely solely on AID without understanding how to revert to manual pump therapy or injections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tandem Insulin Pump Cannula/Needle Changing Frequency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Correction Factor Adjustment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Optimizing Omnipod Settings for Improved Glycemic Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.